A new orally taken, gut-based compound developed by scientists from Nanyang Technological University, Singapore (NTU Singapore), reduces the amount of dietary fat absorbed in the intestines. This differs from most existing weight-loss drugs, which act mainly by suppressing appetite or altering glucose regulation, as well as supplements that claim to boost metabolism to burn more calories.
This article was originally published on MedicalXpress.com

